xylocaine 2% mdv
aspen medical products malaysia sdn bhd - lidocaine -
vaxsafe hvt vaccine (living)
bioproperties pty. ltd. - herpes virus of turkeys (hvt) strain fc 126 - misc. vaccines or anti sera - herpes virus of turkeys (hvt) strain fc 126 vaccine-viral active 4000.0 pfu/dose - immunotherapy - embryonated chicken egg | poultry chicks | chickens | day old chicks | hatchlings - marek's disease | herpes virus of turkeys (hvt)
amitax mdv vial inj
alkem - amikacin - inj - 500mg(buffer agent sodium citrate ip 2.5 w/v,sodium metabisulphite ip 0.66 w/v,methylparaben 0.04 w/v,propylaparaben ip 0.01;%w/ - vial
clivarine mdv 6 ml vial
abbott - reviparin sodium - vial - 6 ml
cevac md rispens concentrate and solvent for suspension for injection for chickens
ceva animal health ltd - marek's disease virus - concentrate and solvent for suspension for injection - live viral vaccine - chickens
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals for aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).
vectormune hvt lt at least 3160 pfu/dose ; formulation: each 0.05 ml (in-ovo) or 0.2 ml (sc) (dose) contains: fowl laryngotracheitis-marek's disease virus min 3,160 pfu* suspension for injection (in-ovo/sc)
ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - recombinant live fowl laryngotracheitis (ilt)-marek's disease virus (mdv) vaccine (vet.) - suspension for injection (in-ovo/sc) - at least 3160 pfu/dose ; formulation: each 0.05 ml (in-ovo) or 0.2 ml (sc) (dose) contains: fowl laryngotracheitis-marek's disease virus min 3,160 pfu*
poulvac procerta hvt-nd formulation: each dose contains: marek's disease virus (hvt strain, serotype 3) ....................... >3,777 pfu newcastle disease (nd) virus (f gene, lentogenic strain) ......... > 3,739 pfu pfu – plaque forming unit suspension for injection (in-ovo/sc)
zoetis philippines, inc.; distributor: zoetis philippines, inc. - live recombinant marek's disease virus (mdv) , newcastle disease (nd) virus vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: marek's disease virus (hvt strain, serotype 3) ....................... >3,777 pfu newcastle disease (nd) virus (f gene, lentogenic strain) ......... > 3,739 pfu pfu – plaque forming unit
prevexxion rn formulation: each dose contains: marek's disease virus, chimera, serotype 1 (rn1250 strain).....≥952 pfu pfu - plaque forming unit suspension for injection (in-ovo/sc)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - live marek's disease virus (mdv) chimera vaccine (vet.) - suspension for injection (in-ovo/sc) - formulation: each dose contains: marek's disease virus, chimera, serotype 1 (rn1250 strain).....≥952 pfu pfu - plaque forming unit
prevenar 13 suspension for injection mdv serotype 6b= 4.4 mcg, 1, 3,4,5,6a,7f,9v,14,18c,19a,19f &23f= 2.2 mcg
مستودع خوري - khoury drug store - pnuemococcal polysaccharide serotypes serotype 6b= 4.4 mcg, pneumococcal polysaccharide serotypes 1, 3,4,5,6a,7f,9v,14,18c,19a,19f &23f= 2.2 mcg - serotype 6b= 4.4 mcg, 1, 3,4,5,6a,7f,9v,14,18c,19a,19f &23f= 2.2 mcg